Twomey J J, Laughter A H, Farrow S, Douglass C C
J Clin Invest. 1975 Aug;56(2):467-75. doi: 10.1172/JCI108113.
Irradiated leukocytes or mononuclear leukocytes, from 16 out of 30 patients with Hodgkin's disease and from one patient with the Sézary syndrome, stimulated in culture subnormal (3H)thymidine incorporation by allogeneic lymphocytes from normal individuals. This abnormality was not demonstrated in any of 30 other patients with non-Hodgkin's lymphomas. Subnormal mixed leukocyte culture reaction activation was caused by suppression of the mixed leukocyte reaction by patients' cells. Inhibition of the reaction by patient mononuclear leukocytes was corrected when adherent cells were removed or when protein synthesis was inhibited with cycloheximide. The inhibitory cells were probably lymphocytes since selective removal of phagocytic cells did not remove the inhibition by other patient mononuclear leukocytes. The presence in culture of as few as 2,500 granulocytes per mm3 also reduced responses when target cells were from patients with Hodgkin's disease. Patient cells no longer suppressed the mixed leukocyte reaction after patients entered clinical remission which suggests that suppression is a reversible, disease-related abnormality. Thus, the immune deficiency with advance Hodgkin's disease caused by ly lymphocyte depletion may be compounded by a relative excess of suppressor lymphocytes. The overall immunodeficiency may be further compounded by suppression of immune response by granulocytes at even physiologic concentrations.
在30例霍奇金病患者中的16例以及1例塞扎里综合征患者体内,经照射的白细胞或单核白细胞在培养过程中会抑制正常个体同种异体淋巴细胞的(3H)胸腺嘧啶核苷掺入,使其低于正常水平。而在30例其他非霍奇金淋巴瘤患者中均未发现这种异常情况。患者细胞对混合淋巴细胞反应的抑制导致混合白细胞培养反应激活低于正常水平。当去除贴壁细胞或用环己酰亚胺抑制蛋白质合成时,患者单核白细胞对反应的抑制作用得到纠正。抑制细胞可能是淋巴细胞,因为选择性去除吞噬细胞并不能消除其他患者单核白细胞的抑制作用。当靶细胞来自霍奇金病患者时,每立方毫米培养物中低至2500个粒细胞的存在也会降低反应。患者进入临床缓解期后,其细胞不再抑制混合淋巴细胞反应,这表明这种抑制是一种与疾病相关的可逆异常。因此,晚期霍奇金病由淋巴细胞耗竭引起的免疫缺陷可能因抑制性淋巴细胞相对过多而加重。即使在生理浓度下,粒细胞对免疫反应的抑制也可能进一步加重整体免疫缺陷。